Other papers submitted by: Dr Samuel Stoddart

open access to scientific and medical research

News:

Expressions of interest for Editor-in-Chief - the International Medical Case Reports Journal Read more

Back to User profile » Dr Samuel Stoddart

Paper published by Dr Samuel Stoddart:

Original Research

Noteworthy comment: In health technology assessment (HTA) agencies where cost-effectiveness plays a role in decision-making, an incremental cost-effectiveness ratio (ICER) threshold is often used to inform reimbursement decisions. Acceptance of submissions with higher-than-threshold ICERs varied by HTA agency and was not significantly influenced by disease category. Such submissions must be accompanied by robust, concrete, and transparent evidence in order to achieve patient access.

Highly-accessed

Acceptance of health technology assessment submissions with incremental cost-effectiveness ratios above the cost-effectiveness threshold

Griffiths EA, Hendrich JK, Stoddart SDR, Walsh SCM

ClinicoEconomics and Outcomes Research 2015, 7:463-476

Published Date: 31 August 2015